MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Synopsis : MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the grant…
Synopsis : MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the grant…